A Clinico-pathological Study of Male Breast Cancer in Yazd, Iran (1992-2007)
Issue: Vol.7, No.3 - July 2008
Article Type: Manuscript
Male breast cancer (MBC) is an uncommon condition. It accounts for less then 1% of all breast cancers and even fewer of all malignancies occurring in men. Between 1992 and 2007, a total of 6673 cancer cases were registered in the pathology department of Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran. Of these 3740 patients(56.46%) were males. Eight of these cases (0.21 %) had breast cancer. The overall male female ratio for MBC was 0.017:1. The mean age of our patients was 63.62 years (SD = 11.63). Stage III and IV disease was observed in 87.5 percent of our patients. Histological analysis revealed that 87.5% of patients had infiltrating ductal carcinoma. Hormone receptor status of the tumor was positive in 87.5 percent of patient for estrogen and progesterone receptor respectively. These observations are discussed for the need for early detection of MBC and national consensus for an evidence based management of MBC in Iran.
Also In This Issue
- Editorial: What is the Role of Complementary Medicine in Modern Cancer Care?
- Profile: Prof. Stephen Clarke
- 'Feeling Very Left Out': Parents Insights on Siblings of Children Treated for Childhood Acute Lymphoblastic Leukaemia
- Molecular Diagnostics of Bone and Soft Tissue Tumours
- Balancing Self-reliance with the Use of Support Mechanisms Amongst Breast Cancer Patients
- Reconsideration of Radiation Therapy for Liver Carcinoma
- Mutational Analysis of the MMAC1 Tumour Suppressor Gene in Patients with Juvenile Polyposis Syndrome and Cowden Disease
- Assessment of Prognostic Factors for Non-Small-Cell Lung Carcinoma Following Radiotherapy of Cerebral Metastases
- Assessment of Normal Tissue Complications and Second Cancer Risks Following Prostate Cancer Irradiation: A Review